{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:18:35Z","timestamp":1762323515919},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,8,5]],"date-time":"2012-08-05T00:00:00Z","timestamp":1344124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s10067-012-2049-6","type":"journal-article","created":{"date-parts":[[2012,8,4]],"date-time":"2012-08-04T07:19:13Z","timestamp":1344064753000},"page":"1567-1575","source":"Crossref","is-referenced-by-count":29,"title":["Serial interferon-\u03b3 release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents"],"prefix":"10.1007","volume":"31","author":[{"given":"Rossana","family":"Scrivo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Sauzullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Mengoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Iaiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Rita","family":"Vestri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Priori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Di Filippo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Di Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca Romana","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Vullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio Maria","family":"Mastroianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Valesini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,5]]},"reference":[{"issue":"Suppl 2","key":"2049_CR1","doi-asserted-by":"crossref","first-page":"i2","DOI":"10.1136\/annrheumdis-2011-201036","volume":"71","author":"DE Furst","year":"2012","unstructured":"Furst DE, Keystone EC, Braun J, Breedveld FC, Burmester GR, De Benedetti F, D\u00f6rner T, Emery P, Fleischmann R, Gibofsky A, Kalden JR, Kavanaugh A, Kirkham B, Mease P, Sieper J, Singer NG, Smolen JS, Van Riel PL, Weisman MH, Winthrop K (2012) Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011. Ann Rheum Dis 71(Suppl 2):i2\u2013i45","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2049_CR2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1473-3099(03)00545-0","volume":"3","author":"MA Gardam","year":"2003","unstructured":"Gardam MA, Keystone EC, Menzies R, Manners S, Skamene E, Long R, Vinh DC (2003) Anti-tumor necrosis factor agents and tuberculosis risk: mechanism of action and clinical management. Lancet Infect Dis 3(3):148\u2013155","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"2049_CR3","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/ard.2009.118935","volume":"69","author":"WG Dixon","year":"2010","unstructured":"Dixon WG, Hyrich KL, Watson KD, Lunt M, Galloway J, Ustianowski A, BSRBR Control Centre Consortium, Symmons DP; BSR Biologics Register (2010) Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR). Ann Rheum Dis 69(3):522\u2013528","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"2049_CR4","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/art.24632","volume":"60","author":"F Tubach","year":"2009","unstructured":"Tubach F, Salmon D, Ravaud P, Allanore Y, Goupille P, Br\u00e9ban M, Pallot-Prades B, Pouplin S, Sacchi A, Chichemanian RM, Bretagne S, Emilie D, Lemann M, Lortholary O, Mariette X, Research Axed on Tolerance of Biotherapies Group (2009) Risk of tuberculosis is higher with antitumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three-year prospective French Research Axed on Tolerance of Biotherapies registry. Arthritis Rheum 60(7):1884\u20131894","journal-title":"Arthritis Rheum"},{"issue":"10","key":"2049_CR5","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1473-3099(08)70227-5","volume":"8","author":"RS Wallis","year":"2008","unstructured":"Wallis RS (2008) Tumour necrosis factor antagonists: structure, function, and tuberculosis risks. Lancet Infect Dis 8(10):601\u2013611","journal-title":"Lancet Infect Dis"},{"key":"2049_CR6","doi-asserted-by":"crossref","unstructured":"Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement (2000) Am J Respir Crit Care Med 161(4 Pt 2):S221\u2013S247","DOI":"10.1164\/ajrccm.161.supplement_3.ats600"},{"issue":"6","key":"2049_CR7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1164\/rccm.200701-024ED","volume":"175","author":"M Pai","year":"2007","unstructured":"Pai M, Menzies D (2007) The new IGRA and the old TST. Making good use of disagreement. Am J Respir Crit Care Med 175(6):529\u2013531","journal-title":"Am J Respir Crit Care Med"},{"issue":"RR-5","key":"2049_CR8","first-page":"1","volume":"59","author":"GH Mazurek","year":"2010","unstructured":"Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K, IGRA Expert Committee; Centers for Disease Control and Prevention (CDC) (2010) Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection\u2014United States, 2010. MMWR Recomm Rep 59(RR-5):1\u201325","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"2049_CR9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1164\/ajrccm.159.1.9801120","volume":"159","author":"D Menzies","year":"1999","unstructured":"Menzies D (1999) Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 159(1):15\u201321","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"2049_CR10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315\u2013324","journal-title":"Arthritis Rheum"},{"issue":"8","key":"2049_CR11","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, Study Group CASPAR (2006) Classification criteria for psoriatic arthritis. Development of new criteria from a large international study. Arthritis Rheum 54(8):2665\u20132673","journal-title":"Arthritis Rheum"},{"issue":"4","key":"2049_CR12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden van der","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 27(4):361\u2013368","journal-title":"Arthritis Rheum"},{"key":"2049_CR13","doi-asserted-by":"crossref","unstructured":"International Study Group for Behcet\u2019s Disease: Criteria for diagnosis of Behcet\u2019s disease (1990) Lancet 335(8697):1078\u20131080","DOI":"10.1016\/0140-6736(90)92643-V"},{"key":"2049_CR14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1465-9921-7-56","volume":"7","author":"I Brock","year":"2006","unstructured":"Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, Ravn P (2006) Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir Res 7:56","journal-title":"Respir Res"},{"issue":"9519","key":"2049_CR15","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(06)68579-6","volume":"367","author":"G Ferrara","year":"2006","unstructured":"Ferrara G, Losi M, D\u2019Amico R, Roversi P, Piro R, Meacci M, Meccugni B, Dori IM, Andreani A, Bergamini BM, Mussini C, Rumpianesi F, Fabbri LM, Richeldi L (2006) Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 367(9519):1328\u20131334","journal-title":"Lancet"},{"issue":"10","key":"2049_CR16","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s10096-008-0519-1","volume":"27","author":"M Bocchino","year":"2008","unstructured":"Bocchino M, Matarese A, Bellofiore B, Giacomelli P, Santoro G, Balato N, Castiglione F, Scarpa R, Perna F, Signoriello G, Galati D, Ponticiello A, Sanduzzi A (2008) Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment. Eur J Clin Microbiol Infect Dis 27(10):907\u2013913","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"2049_CR17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.2007.070789","volume":"67","author":"G Matulis","year":"2008","unstructured":"Matulis G, Juni P, Villiger PM, Gadola SD (2008) Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay. Ann Rheum Dis 67(1):84\u201390","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2049_CR18","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/art.23705","volume":"59","author":"DY Chen","year":"2008","unstructured":"Chen DY, Shen GH, Hsieh TY, Hsieh CW, Lan JL (2008) Effectiveness of the combination of a whole blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy. Arthritis Rheum 59(6):800\u2013806","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2049_CR19","first-page":"776","volume":"35","author":"D Ponce de Leon","year":"2008","unstructured":"Ponce de Leon D, Acevedo-Vasquez E, Alvizuri S, Gutierrez C, Cucho M, Alfaro J, Perich R, Sanchez-Torres A, Pastor C, Sanchez-Schwartz C, Medina M, Gamboa R, Ugarte M (2008) Comparison of an interferon gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. J Rheumatol 35(5):776\u2013781","journal-title":"J Rheumatol"},{"issue":"7","key":"2049_CR20","first-page":"834","volume":"14","author":"I Sauzullo","year":"2010","unstructured":"Sauzullo I, Mengoni F, Scrivo R, Valesini G, Potenza C, Skroza N, Marocco R, Lichtner M, Vullo V, Mastroianni CM (2010) Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumor necrosis factor-alpha treatment. Int J Tuberc Lung Dis 14(7):834\u2013840","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"2049_CR21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/ard.2008.101857","volume":"69","author":"J Martin","year":"2010","unstructured":"Martin J, Walsh C, Gibbs A, McDonnell T, Fearon U, Keane J, Codd MB, Dodd J, Veale D, Fitzgerald O, Bresnihan B (2010) Comparison of interferon gamma release assays and conventional screening tests before tumour necrosis factor alpha blockade in patients with inflammatory arthritis. Ann Rheum Dis 69(1):181\u2013185","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2049_CR22","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1164\/rccm.200502-196OC","volume":"172","author":"G Ferrara","year":"2005","unstructured":"Ferrara G, Losi M, Meacci M, Meccugni B, Piro R, Roversi P, Bergamini BM, D\u2019Amico R, Marchegiano P, Rumpianesi F, Fabbri LM, Richeldi L (2005) Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 172(5):631\u2013635","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"2049_CR23","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1183\/09031936.00028510","volume":"36","author":"I Solovic","year":"2010","unstructured":"Solovic I, Sester M, Gomez-Reino JJ, Rieder HL, Ehlers S, Milburn HJ, Kampmann B, Hellmich B, Groves R, Schreiber S, Wallis RS, Sotgiu G, Sch\u00f6lvinck EH, Goletti D, Zellweger JP, Diel R, Carmona L, Bartalesi F, Ravn P, Bossink A, Duarte R, Erkens C, Clark J, Migliori GB, Lange C (2010) The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur Respir J 36(5):1185\u20131206","journal-title":"Eur Respir J"},{"issue":"2","key":"2049_CR24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/annrheumdis-2011-200489","volume":"71","author":"DY Chen","year":"2012","unstructured":"Chen DY, Shen GH, Chen YM, Chen HH, Hsieh CW, Lan JL (2012) Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNF{alpha} inhibitors: the utility of IFN{gamma} assay. Ann Rheum Dis 71(2):231\u2013237","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"2049_CR25","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/ard.2009.113829","volume":"69","author":"S Kleinert","year":"2010","unstructured":"Kleinert S, Kurzai O, Elias J, Marten K, Engelke C, Feuchtenberger M, Sandstede J, Frosch M, Tony HP, Kneitz C (2010) Comparison of two interferon-gamma release assays and tuberculin skin test for detecting latent tuberculosis in patients with immune-mediated inflammatory diseases. Ann Rheum Dis 69(4):782\u2013784","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"2049_CR26","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/ibd.21605","volume":"17","author":"E B\u00e9lard","year":"2011","unstructured":"B\u00e9lard E, Semb S, Ruhwald M, Werlinrud AM, Soborg B, Jensen FK, Thomsen H, Brylov A, Hetland ML, Nordgaard-Lassen I, Ravn P (2011) Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection. Inflamm Bowel Dis 17(11):2340\u20132349","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"2049_CR27","first-page":"1271","volume":"35","author":"D Vassilopoulos","year":"2008","unstructured":"Vassilopoulos D, Stamoulis N, Hadziyannis E, Archimandritis AJ (2008) Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. J Rheumatol 35(7):1271\u20131276","journal-title":"J Rheumatol"},{"issue":"7","key":"2049_CR28","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1128\/CVI.00132-07","volume":"14","author":"EM Leyten","year":"2007","unstructured":"Leyten EM, Arend SM, Prins C, Cobelens FG, Ottenhoff TH, van Dissel JT (2007) Discrepancy between mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation. Clin Vaccine Immunol 14(7):880\u2013885","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"2049_CR29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10067-010-1550-z","volume":"30","author":"AJ Kwakernaak","year":"2011","unstructured":"Kwakernaak AJ, Houtman PM, Weel JF, Spoorenberg JP, Jansen TL (2011) A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor \u03b1 inhibitor. Clin Rheumatol 30(4):505\u2013510","journal-title":"Clin Rheumatol"},{"issue":"5","key":"2049_CR30","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/art.22768","volume":"57","author":"JJ Gomez-Reino","year":"2007","unstructured":"Gomez-Reino JJ, Carmano L, Descalzo A, BIOBADASER GROUP (2007) Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. Arthritis Rheum 57(5):756\u2013761","journal-title":"Arthritis Rheum"},{"issue":"10","key":"2049_CR31","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.3899\/jrheum.090150","volume":"36","author":"JH Park","year":"2009","unstructured":"Park JH, Seo GY, Lee JS, Kim TH, Yoo DH (2009) Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during antitumor necrosis factor agent trial. J Rheumatol 36(10):2158\u20132163","journal-title":"J Rheumatol"},{"issue":"12","key":"2049_CR32","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00296-007-0361-2","volume":"27","author":"H Takahashi","year":"2007","unstructured":"Takahashi H, Shigehara K, Yamamoto M, Suzuki C, Naishiro Y, Tamura Y, Hirohashi Y, Satoh N, Shijubo N, Shinomura Y, Imai K (2007) Interferon \u03b3 assay for detecting latent tuberculosis infection in rheumatoid arthritis patients during infliximab administration. Rheumatol Int 27(12):1143\u20131148","journal-title":"Rheumatol Int"},{"key":"2049_CR33","doi-asserted-by":"crossref","unstructured":"Garcovich S, Ruggeri A, D\u2019Agostino M, Ardito F, De Simone C, Delogu G, Fadda G (2012) Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study. J Eur Acad Dermatol Venereol. doi: 10.1111\/j.1468-3083.2011.04220.x","DOI":"10.1111\/j.1468-3083.2011.04220.x"},{"issue":"4","key":"2049_CR34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3343\/kjlm.2011.31.4.271","volume":"31","author":"KH Kim","year":"2011","unstructured":"Kim KH, Lee SW, Chung WT, Kim BG, Woo KS, Han JY, Kim JM (2011) Serial interferon-gamma release assays for the diagnosis of latent tuberculosis infection in patients treated with immunosuppressive agents. Korean J Lab Med 31(4):271\u2013278","journal-title":"Korean J Lab Med"},{"issue":"5","key":"2049_CR35","first-page":"790","volume":"29","author":"JS Ringrose","year":"2011","unstructured":"Ringrose JS, Sanche SE, Taylor-Gjevre RM (2011) Detecting latent tuberculosis infection during antitumor necrosis factor therapy. Clin Exp Rheumatol 29(5):790\u2013794","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"2049_CR36","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1086\/381754","volume":"38","author":"S Carrara","year":"2004","unstructured":"Carrara S, Vincenti D, Petrosillo N, Amicosante M, Girardi E, Goletti D (2004) Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis 38(5):754\u2013756","journal-title":"Clin Infect Dis"},{"issue":"10","key":"2049_CR37","first-page":"1146","volume":"12","author":"SK Katiyar","year":"2008","unstructured":"Katiyar SK, Sampath A, Bihari S, Mamtani M, Kulkarni H (2008) Use of the QuantiFERON-TB Gold In-Tube test to monitor treatment efficacy in active pulmonary tuberculosis. Int J Tuberc Lung Dis 12(10):1146\u20131152","journal-title":"Int J Tuberc Lung Dis"},{"key":"2049_CR38","doi-asserted-by":"crossref","first-page":"e5187","DOI":"10.1371\/journal.pone.0005187","volume":"4","author":"I Sauzullo","year":"2009","unstructured":"Sauzullo I, Mengoni F, Lichtner M, Massetti AP, Rossi R, Iannetta M, Marocco R, Del Borgo C, Soscia F, Vullo V, Mastroianni CM (2009) In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T cell response. PLoS One 4:e5187","journal-title":"PLoS One"},{"key":"2049_CR39","doi-asserted-by":"crossref","first-page":"e1850","DOI":"10.1371\/journal.pone.0001850","volume":"3","author":"A Veerapathran","year":"2008","unstructured":"Veerapathran A, Joshi R, Goswami K, Dogra S, Moodie EE, Reddy MV, Kalantri S, Schwartzman K, Behr MA, Menzies D, Pai M (2008) T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data. PLoS One 3:e1850","journal-title":"PLoS One"},{"issue":"8","key":"2049_CR40","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1128\/JCM.00482-10","volume":"48","author":"V Herrera","year":"2010","unstructured":"Herrera V, Yeh E, Murphy K, Parsonnet J, Banaei N (2010) Immediate incubation reduces indeterminate results for QuantiFERON-TB Gold in-tube assay. J Clin Microbiol 48(8):2672\u20132676","journal-title":"J Clin Microbiol"},{"key":"2049_CR41","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1186\/ar1994","volume":"8","author":"H Hamdi","year":"2006","unstructured":"Hamdi H, Mariette X, Godot V, Weldingh K, Hamid AM, Prejean MV, Baron G, Lemann M, Puechal X, Breban M, Berenbaum F, Delchier JC, Flipo RM, Dautzenberg B, Salmon D, Humbert M, Emilie D, RATIO (Recherche sur Anti-TNF et Infections Opportunistes) Study Group, (2006) Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists. Arthritis Res Ther 8:R114","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"2049_CR42","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1183\/09031936.00117506","volume":"29","author":"EM Leyten","year":"2007","unstructured":"Leyten EM, Prins C, Bossink AW, Thijsen S, Ottenhoff TH, van Dissel JT, Arend SM (2007) Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-gamma assay. Eur Respir J 29(6):1212\u20131216","journal-title":"Eur Respir J"},{"issue":"2","key":"2049_CR43","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1183\/09031936.00014508","volume":"32","author":"L Richeldi","year":"2008","unstructured":"Richeldi L, Bergamini BM, Vaienti F (2008) Prior tuberculin skin testing does not boost QuantiFERON-TB results in paediatric contacts. Eur Respir J 32(2):524\u2013525","journal-title":"Eur Respir J"},{"issue":"4","key":"2049_CR44","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.tube.2011.05.004","volume":"91","author":"I Sauzullo","year":"2011","unstructured":"Sauzullo I, Massetti AP, Mengoni F, Rossi R, Lichtner M, Ajassa C, Vullo V, Mastroianni CM (2011) Influence of previous tuberculin skin test on serial IFN-\u03b3 release assays. Tuberculosis 91(4):322\u2013326","journal-title":"Tuberculosis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-012-2049-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-012-2049-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-012-2049-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T10:45:50Z","timestamp":1562064350000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-012-2049-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,5]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["2049"],"URL":"https:\/\/doi.org\/10.1007\/s10067-012-2049-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,5]]}}}